BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 30127609)

  • 1. T
    Li J; You J; Wu C; Dai Y; Shi M; Dong L; Xu K
    Int J Nanomedicine; 2018; 13():4607-4625. PubMed ID: 30127609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T
    Gao L; Yu J; Liu Y; Zhou J; Sun L; Wang J; Zhu J; Peng H; Lu W; Yu L; Yan Z; Wang Y
    Theranostics; 2018; 8(1):92-108. PubMed ID: 29290795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-Directed Specific Drug Delivery and Magnetic Resonance Imaging of Renal Carcinoma Cells In Vitro and In Vivo.
    Li J; Wang J; Sun D; Dai Y; Shen J; You J; Han C; Xu K
    J Biomed Nanotechnol; 2016 Aug; 12(8):1604-616. PubMed ID: 29342341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Fe3O4/SiO2/Gd2O(CO3)2 core/shell/shell nanoparticles as T1 and T2 dual mode MRI contrast agent.
    Yang M; Gao L; Liu K; Luo C; Wang Y; Yu L; Peng H; Zhang W
    Talanta; 2015 Jan; 131():661-5. PubMed ID: 25281156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activatable molecular MRI nanoprobe for tumor cell imaging based on gadolinium oxide and iron oxide nanoparticle.
    Li J; Wang S; Wu C; Dai Y; Hou P; Han C; Xu K
    Biosens Bioelectron; 2016 Dec; 86():1047-1053. PubMed ID: 27501342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
    Li J; Wu C; Hou P; Zhang M; Xu K
    Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd
    Kadria-Vili Y; Neumann O; Zhao Y; Nordlander P; Martinez GV; Bankson JA; Halas NJ
    Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2123527119. PubMed ID: 35858309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
    Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
    Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo.
    Tian X; Yang F; Yang C; Peng Y; Chen D; Zhu J; He F; Li L; Chen X
    Int J Nanomedicine; 2014; 9():4043-53. PubMed ID: 25187708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core/shell Fe3O4/Gd2O3 nanocubes as T1-T2 dual modal MRI contrast agents.
    Li F; Zhi D; Luo Y; Zhang J; Nan X; Zhang Y; Zhou W; Qiu B; Wen L; Liang G
    Nanoscale; 2016 Jul; 8(25):12826-33. PubMed ID: 27297334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies.
    Mortezazadeh T; Gholibegloo E; Alam NR; Dehghani S; Haghgoo S; Ghanaati H; Khoobi M
    MAGMA; 2019 Aug; 32(4):487-500. PubMed ID: 30730021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent.
    Dai Y; Wu C; Wang S; Li Q; Zhang M; Li J; Xu K
    Nanomedicine; 2018 Feb; 14(2):547-555. PubMed ID: 29253637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physico-chemical and MR relaxometry study of bovine serum albumin-coated magneto-plasmonic nanoparticles designed for potential use in cancer nanotheranostics.
    Alipanah-Poor K; Sheervalilou R; Irajirad R; Sarikhani A; Tavangari Z; Alamzadeh Z; Ghaznavi H; Khoei S
    Magn Reson Imaging; 2023 Nov; 103():208-215. PubMed ID: 37348741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox ferrocenylseleno compounds modulate longitudinal and transverse relaxation times of FNPs-Gd MRI contrast agents for multimodal imaging and photo-Fenton therapy.
    Zhou T; Zhang S; Zhang L; Jiang T; Wang H; Huang L; Wu H; Fan Z; Jing S
    Acta Biomater; 2023 Jul; 164():496-510. PubMed ID: 37054962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment responsive
    Liang M; Zhou W; Zhang H; Zheng J; Lin J; An L; Yang S
    J Mater Chem B; 2023 May; 11(19):4203-4210. PubMed ID: 37114335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual T
    Suárez-García S; Arias-Ramos N; Frias C; Candiota AP; Arús C; Lorenzo J; Ruiz-Molina D; Novio F
    ACS Appl Mater Interfaces; 2018 Nov; 10(45):38819-38832. PubMed ID: 30351897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Magnus nano-bullets" as T
    Khatik R; Wang Z; Li F; Zhi D; Kiran S; Dwivedi P; Xu RX; Liang G; Qiu B; Yang Q
    Nanomedicine; 2019 Jan; 15(1):264-273. PubMed ID: 30442595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Performance
    Zhao D; Peng S; Xiao H; Li Q; Chai Y; Sun H; Liu R; Yao L; Ma L
    ACS Appl Bio Mater; 2023 Jun; 6(6):2137-2144. PubMed ID: 37229527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of Gadolinium Oxide Nanoparticle (Gd
    Mekuria SL; Debele TA; Tsai HC
    ACS Appl Mater Interfaces; 2017 Mar; 9(8):6782-6795. PubMed ID: 28164704
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
    J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.